Amelioration of cisplatin induced nephrotoxicity by PTY: A herbal preparation

Food and Chemical Toxicology

Volumn 48, Issue 8-9, 2010, Pages 2253-2258

  Nagwani, Santosh ^a   Tripathi, Yamini B ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Anti oxidant; Ayurveda; Food supplements; Herbal; Nephroprotective

Indexed keywords

CATALASE; CISPLATIN; CREATININE; DNA; FLAVONOID; GLUTATHIONE; HERBACEOUS AGENT; METHANOL; NITROGEN; PHENOL DERIVATIVE; PTY; PUERARIA EXTRACT; PUERARIA TUBEROSA EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; UREA; ANTINEOPLASTIC AGENT; ANTIOXIDANT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA DAMAGE; DNA FRAGMENTATION; DOSE RESPONSE; DRUG ISOLATION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; KIDNEY FUNCTION TEST; MALE; NEPHROTOXICITY; NONHUMAN; PUERARIA; PUERARIA TUBEROSA; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; KIDNEY; KIDNEY DISEASES; PATHOLOGY; PHYTOTHERAPY; TOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; CREATININE; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, AGAR GEL; FEMALE; KIDNEY; KIDNEY DISEASES; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT PREPARATIONS; RATS; UREA;

PUERARIA TUBEROSA; RATTUS;

EID: 77955054132     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.05.057     Document Type: Article

References (49)

1. Anon., 2006. The Ayurvedic Pharmacopoeia of India, Part I, vol. V, first ed., Ministry of Health and Family Welfare, New Delhi, 193-194.
2. Aebi, H.E., 1983. Catalase. In: Burgmeyer, H.U. (Ed.), Methods of Enzymatic Analysis, vol. 3(3). Academic Press, New York, p. 273.
3. Alijanabi S.M., Martinez I. Universal and rapid salt extraction high quality genomic DNA for PCR based techniques. Nucleic Acids Res. 1997, 25:4692-4693.
4. Badary O.A., Nagi M.N., Al-Shabanah O.A., Al-Sawaf H.A., Al-Sohaibani M.O., Al-Bekairi A.M. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can. J. Physio. Pharmacol. 1997, 75(12):1356-1361.
5. Basnakian A.G., Apostolov E.O., Yin X., Napirei M., Mannherz H.G., Shah S.V. Cisplatin nephrotoxicity is mediated by deoxyribonuclease I. J. Am. Soc. Nephrol. 2005, 16:697-702.
6. Boyne A.F., Ellman G.L. A methodology for analysis of tissue sulfhydryl components. Anal. Biochem. 1972, 46(2):639-653.
7. Chirino Y.I., Trujillo J., Sanchez-Gonzalez D.J., Martinez-Martinez C.M., Cruz C., Bobadilla N.A., Pedraza-Chaverri J. Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol. Lett. 2008, 176:48-57.
8. Cornelison T.L., Reed E. Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin. Gynecol. Oncol. 1993, 50:147-158.
9. Fawcett J.K., Scott J.E. A rapid and precise method for the determination of urea. J. Clin. Pathol. 1960, 13:156-159.
10. Faubel S., Lewis E.C., Reznikov L., Ljubanovic D., Hoke T.S., Somerset H., Oh D.J., Lu L., Klein C.L., Dinarello C.A., Edelstein C.L. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J. Pharmacol. Exp. Ther. 2007, 322:8-15.
11. Gately D.P., Howell S.B. Cellular accumulation of the anticancer agent cisplatin: a review. Br. J. Cancer 1993, 67:1171-1176.
12. Goyal S., Ramawat K.G. Effect of chemical factors on production of isoflavonoids in Pueraria tuberosa (Roxb.ex. Willd.) DC suspension culture. Ind. J. Med. Res. 2007, 45:1063-1067.
13. Gupta R.S., Sharma R., Sharma A. Antifertility effects of Pueraria tuberosa root extract in male rats. Pharm. Biol. 2004, 42(8):603-609.
14. Halliwell B. Reactive species and antioxidants redox biology is a fundamental theme of aerobic life. Plant Physiol. 2006, 141:312-322.
15. Hanigen M.H., Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 2003, 1:47-61.
16. Hsu L.F., Liu M.I., Kuo H.D., Chen C.W., Su C.H., Cheng T.J. Antihyperglycemic effect of Puerarin in streptozotocin-induced rats. J. Nat. Prod. 2003, 66:788-792.
17. Joshi B.N., Kamat V.N., Govindachari T.R. Structure of tuberosin, a new pterocarpan from Pueraria tuberosa. Ciba Research Centre Bombay, India. Ind. J. Chem. 1972, 1011:1112-1113.
18. Kang D.G., Lee A.S., Mun Y.J., Woo W.H., Kim Y.C., Sohn E.J. Butein ameliorate renal concentration ability in cisplatin-induced acute renal failure. Biol. Pharm. Bull. 2004, 27:366-370.
19. Kawai Y., Nakao T., Kunimura N., Kohda Y., Gemba M. Relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury. J. Pharmacol. Sci. 2006, 100:65-72.
20. Kuhlmann M.K., Burkhardt G., Kohler H. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol. Dial. Transplant. 1997, 12:2478-2480.
21. Lau A.H. Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int. 1999, 56:1295-1298.
22. Larsen K. Creatinine assay by a reaction-kinetic principle. Clin. Chim. Acta. 1972, 41:209-217.
23. Lowry O.H., Rosebrough A.L., Earr K.J., Randall K.J. Protein measurements with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
24. Ludwig T., Riethmuller C., Gekle M., Schwerdt G., Oberleithner H. Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. Kidney Int. 2004, 66:196-202.
25. Matsushima H., Yonemura K., Ohishi K., Hishida A. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J. Lab. Clin. Med. 1998, 131:518-526.
26. McCord J.M., Fridovich I. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969, 244:6049-6055.
27. Meda A., Lamien C.E., Romito M., Millogo J., Nacoulma O.G. Determination of the total phenolic, flavonoid and proline contents in Burkina Fasan honey, as well as their radical scavenging activity. Food Chem. 2005, 91:571-577.
28. Meyer K.N. Cisplatin nephrotoxicity. Min. Electro. Metabol. 1994, 20:201-213.
29. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
30. Pabla N., Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008, 73:994-1007.
31. Pandey, G.S., Chunekar, K.C., 1998. In: Vidari Kand, Bhav Prakash Nighantu, (Eds.), vol. 1. Chaukambha Vidya Bhavan, Varanasi, pp. 388-389.
32. Pandey N., Chaurasia J.K., Tiwari O.P., Tripathi Y.B. Antioxidant properties of different fractions of tubers from Pueraria tuberosa. Food Chem. 2007, 105:219-222.
33. Ries F., Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am. J. Kidney Dis. 1986, 8:368-379.
34. Shukla S., Jonathan S., Sharma A. Protective action of butanolic extract of Pueraria tuberosa DC against carbon tetrachloride induced hepatotoxicity in adult rats. Phytother. Res. 1996, 10(7):608-609.
35. Singleton V.L., Orthofer R., Lamuela-Raventos R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol. 1999, 299:152-178.
36. Somani S., Husain K., Whitworth C., Trammell G., Malafa M., Rybak L. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol. Toxicol. 2000, 86(5):234-241.
37. Somani S.M., Ravi R., Rybak L.P. Diethyldithiocarbamate protection against cisplatin nephrotoxicity: antioxidant system. Drug Chem. Toxicol. 1995, 18(2-3):151-170.
38. Sugiyama S., Hayakawa M., Kato T., Hanaki Y., Shimizu K., Ozawa T. Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: disturbances in glutathione peroxidase activity. Biochem. Biophys. Res. Commun. 1989, 159:1121-1127.
39. Saad A.A., Youssef M.I., El-Shennawy L.K. Cisplatin induced damage in kidney genomic DNA and nephrotoxicity in male rats: the protective effect of grape seed proanthocyanidin extract. Food Chem. Toxicol. 2009, 47:1499-1506.
40. Townsend D.M., Deng M., Zhang L., Lapus M.G., Hanigan M.H. Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells. J. Am. Soc. Nephrol. 2003, 14:1-10.
41. Tripathi Y.B., Tripathi P., Arjmandi B.H. Nutraceuticals and cancer management. Front. Biosci. 2005, 10:1607-1618.
42. Tanwar Y.S., Goyal S., Ramawat K.G. Hypolipidemic effects of tubers of Indian kudzu (Pueraria tuberosa). J. Herbal Med. Toxicol. 2008, 2(1):21-25.
43. Tripathi Y.B., Sharma M. Comparison of antioxidant action of alcoholic extract of Rubia cordifolia with rubiadin. Ind. J. Biochem. Biophys. 1998, 35:313-316.
44. Tripathi Y.B., Shukla S., Sharma M., Shukla V.K. Antioxidant property of Rubia cordifolia extract and its comparison with vitamin E and parabenzoquinone. Phytother. Res. 1995, 9:440-443.
45. Tripathi Y.B., Singh V.P. Role of Tamra bhasma, an Ayurvedic preparation, in the management of lipid peroxidation in liver of albino rats. Ind. J. Exp. Biol. 1996, 34:66-70.
46. Wang D., Lippard S.J. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 2005, 4:307-320.
47. Yao X., Panichpisal K., Kurtzman N., Nugent K. Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 2007, 334(2):115-124.
48. Yilmaz H.R., Iraz M., Sogut S., Ozyurt Z.Y., Akyol O., Gergerlioglu S. The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol. Res. 2004, 50:287-290.
49. Yoshida M., Khokhar A., Kido Y., Ali-Osman F., Siddik Z. Correlation of total and interstrand DNA adducts in tumor and kidney with antitumor efficacies and differential nephrotoxicities of cisammine/cyclohexylamine-dichloroplatinum (II) and cisplatin. Biochem. Pharmacol. 1994, 17:793-799.